Physician

Adrienne Y Mccray, D.O.

According to 2025 Medicare claims, Adrienne Mccray, D.O. (NPI: 1518003417) practices psychiatry in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is SOUTH COMMUNITY INC (NPI: 1639128176; TIN: 31-0840585) and primary practice location at 45439-1983.

Mccray's data goes back to 2015 and runs through 2024. Part D data shows 138 prescription claims totaling $47,194 in drug costs, led by Invega Sustenna (Paliperidone Palmitate). Open Payments data shows 32 records totaling $679. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $15,683 to $47,194. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	223	$15,683
2016	N/R	223	$12,276
2017	N/R	156	$10,685
2018	N/R	89	$12,120
2019	N/R	88	$13,063
2020	N/R	96	$26,562
2021	N/R	98	$31,823
2022	N/R	98	$31,808
2023	N/R	105	$34,178
2024	N/R	138	$47,194

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Invega Sustenna	Paliperidone Palmitate	16	466	$41,284
Quetiapine Fumarate	Quetiapine Fumarate	61	1,792	$2,859
Risperidone	Risperidone	12	360	$2,208
Topiramate	Topiramate	11	330	$186

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$679	Supernus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adrienne Y. Mccray, D.O.?

Tedicare shows public-source Medicare data for Adrienne Y. Mccray, D.O. (NPI 1518003417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrienne Y. Mccray, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrienne Y. Mccray, D.O.?

Adrienne Y. Mccray, D.O. is linked to SOUTH COMMUNITY INC (billing NPI 1639128176) in the available physician profile data.

Does Adrienne Y. Mccray, D.O. have Open Payments data?

Adrienne Y. Mccray, D.O. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.